RxDoctor Payments Data

Hoan-Vu Nguyen, MD

Orthopaedic Surgery · Ocean, NJNPI 1922067909

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,166 of the $5,212 with a category attached, or 79.9%. Medtronic accounts for 69.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $1,901 and has fallen 56.1% since, to $834 in 2025.

$5,212in general payments, 2019–2025

Across 128 payments — averaging $40.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Globus Medical$468
  • Stryker$407
  • 4web, Inc.$358
  • Johnson & Johnson$75
  • Nevro Corp.$65
  • plus $218 from 8 others

What the payments were for

  • Travel & lodging$1,04620%
  • Food & beverage$4,16680%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,212 in reported general payments places this provider in the 60th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey →

Medicare billing

Part B allowed, 2024
$55,077
Medicare patients
193
Services billed
619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl47$621
Gabapentin26$409
Naproxen44$325
Tizanidine Hcl43$253
Methocarbamol13$76
Meloxicam11$19

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Ocean

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →